VXRT — Vaxart Income Statement
0.000.00%
Last trade - 00:00
- $224.51m
- $166.19m
- $7.38m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9.86 | 4.05 | 0.892 | 0.107 | 7.38 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 25.7 | 34.2 | 69.9 | 108 | 90.7 |
Operating Profit | -15.9 | -30.2 | -69 | -108 | -83.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -18.2 | -32 | -70.4 | -108 | -82.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -18.6 | -32.2 | -70.5 | -108 | -82.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -18.6 | -32.2 | -70.5 | -108 | -82.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -18.6 | -32.2 | -70.5 | -108 | -82.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.713 | -0.371 | -0.584 | -0.858 | -0.569 |